Child & Adolescent Psychopharmacology 2027 is an annual in-person continuing medical education conference hosted by the Massachusetts General Hospital Psychiatry Academy. Scheduled from March 12 to March 14, 2027, at AULANI, A Disney Resort & Spa in Hawaii, the conference addresses complex challenges and evolving clinical guidelines in the care of young psychiatric patients. These emerging areas encompass new diagnostic criteria, patient-centered care models, evolving trends in substance abuse, and genetic research advances. Designed for psychiatrists, pediatricians, primary care and family practice physicians, psychologists, nursing professionals, social workers, residents, and other mental health clinicians, the program delivers comprehensive insights to optimize the assessment, pharmacological treatment, and overall management of children and adolescents experiencing psychiatric conditions.
The educational curriculum covers critical topics across pediatric mental health, differentiating typical developmental behaviors from psychiatric illness. Core modules focus on pediatric mood disorders, depression, antidepressant black box warnings and youth suicide, bipolar disorder, and nutraceutical approaches. Additional modules explore schizophrenia, adolescent substance use disorders, obsessive-compulsive disorder, Tourette's disorder, tics, PANDAS, and pediatric anxiety disorders. Extensive sessions are dedicated to attention deficit hyperactivity disorder (ADHD) across the life cycle, covering pharmacological interventions, educational impacts, cognitive behavioral therapy (CBT), and functional outcomes. The conference also reviews dialectical behavior therapy (DBT), resiliency integration, and the neural underpinnings, presentation, and pharmacological treatment of autism spectrum disorder, along with its comorbidities.
Accreditation for the activity designates up to 14.50 AMA PRA Category 1 Credits™ for physicians through joint providership with McLean Hospital and Massachusetts General Hospital. Additional approved credit types include 14.50 AAPA Category 1 CME, 14.50 Nursing Contact Hours, 14.50 Social Workers continuing education hours, 14.50 Psychologists CE Credit, 14.50 ACPE contact hours (1.0 CEUs) for pharmacists, and 14.50 Interprofessional Continuing Education (IPCE) credits.
Registration pricing tiers for MDs and doctoral-level professionals are $940.00 for Super Early Bird (by December 31, 2026), $1040.00 for Early Bird (January 1 to January 22, 2027), and $1140.00 for Regular Registration. For other professionals or trainees, fees are $840.00 for Super Early Bird, $940.00 for Early Bird, and $1040.00 for Regular Registration. An optional printed syllabus is available for $95.00, while digital e-syllabus access is provided complimentary to all attendees.
Fees (as published by the organiser): MDs/Doctoral-Level Professionals: Super Early Bird Registration (by December 31, 2026): $940.00; Early Bird Registration (January 1 - January 22, 2027): $1040.00; Regular Registration (after January 22, 2027): $1140.00. Other Professionals or Trainees: Super Early Bird Registration (by December 31, 2026): $840.00; Early Bird Registration (January 1 - January 22, 2027): $940.00; Regular Registration (after January 22, 2027): $1040.00. Optional Printed Syllabus: $95.00.
Credits: 14.50 AAPA Category 1 CME 14.50 AMA PRA Category 1 Credit™ 14.50 Nursing Contact Hours 14.50 Social Workers 14.50 Participation 14.50 Psychologists CE Credit
Faculty / directors: Timothy E. Wilens, MD, Chief, Division of Child and Adolescent Psychiatry; (Co) Director, Center for Addiction Medicine; Professor of Psychiatry; President-Elect, American Academy of Child and Adolescent Psychiatry, Massachusetts General Hospital, Harvard Medical School; Janet Wozniak, MD, Associate Professor of Psychiatry; Associate Chief, Quality and Safety, Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital; John A. Fromson, MD, Professor of Clinical Psychiatry; Acting Director, Massachusetts General Hospital Psychiatry Academy; Director of Professional Development, Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Brigham and Women's Hospital; Erica Greenberg, MD, Director, Pediatric Psychiatry OCD and Tic Disorders Program; Assistant Professor, Department of Psychiatry; Psychiatrist, Harvard Medical School, Massachusetts General Hospital; Aude Henin, PhD, Founding Co-Director, Child Cognitive-Behavioral Therapy Program; Clinical Director, Child Resiliency Program; Director of Psychotherapy Services, Gender Identity Program, Department of Psychiatry, Massachusetts General Hospital; Gagan Joshi, MD, Director, The Alan & Lorraine Bressler Program for Autism Spectrum Disorder; Associate Professor of Psychiatry, Massachusetts General Hospital, Harvard Medical School; Aaron R. Quiggle, MD, MS, Medical Director, Addiction Recovery Management Services (ARMS); Instructor, Harvard Medical School; Mai Uchida, MD, Associate Professor, Department of Psychiatry; Director of Pediatric Depression/Director of Global Advocacy, Division of Child and Adolescent Psychiatry, Harvard Medical School, Massachusetts General Hospital